Skip to main content
ALLURION TECHNOLOGIES, INC. logo

ALLURION TECHNOLOGIES, INC. — Investor Relations & Filings

Ticker · ALUR ISIN · US02008G1022 US Human health and social work activities
Open in API
Filings indexed 303 across all filing types
Latest filing 2025-02-14 Regulatory Filings
Country US United States of America
Listing US ALUR

About ALLURION TECHNOLOGIES, INC.

https://www.allurion.com/en

Allurion Technologies, Inc. is a company focused on ending obesity through its comprehensive weight-loss platform, the Allurion Program. The program's core component is a procedure-less, swallowable gastric balloon that is placed during an outpatient visit and passes naturally after approximately four months. This device is integrated into a full-stack solution that includes a digital ecosystem for real-time progress tracking via connected devices, an AI-powered coaching assistant, and personalized support from a multidisciplinary team of healthcare professionals. The platform is designed to promote sustainable, metabolically healthy weight loss by combining appetite regulation with behavioral change support. It can function as a standalone treatment or in combination with other therapies, including the company's AI-native compounded GLP-1 program.

Recent filings

Filing Released Lang Actions
424B3
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC by Allurion Technologies, Inc. It includes a press release about the relaunch of a product in France and clinical trial plans. The document is a regulatory filing reporting a current event rather than a financial report, earnings release, or other specific report type. It does not contain financial statements or detailed financial analysis. The document also includes a prospectus supplement referencing a registration statement. Given the nature of the filing as a current report on Form 8-K with a press release, it fits best under Regulatory Filings (RNS).
2025-02-14 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Allurion Technologies, Inc. It includes a press release about the relaunch of a product in France and clinical trial plans. The document is a regulatory filing reporting a material event (relaunch and regulatory clearance) and does not contain financial statements or detailed financial analysis. It is not an earnings release, annual report, or other financial report. The document is over 13,000 characters, so it is not a brief announcement of a report publication. The primary content is a current report on a significant event, which fits the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2025-02-14 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes a press release about the relaunch of a product in France after regulatory clearance. There are no financial statements or detailed financial data included, and the document is relatively short (3209 characters). It primarily serves as an announcement of an event rather than a detailed financial or management report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-02-13 English
Regulatory Filings 2025
Regulatory Filings
2025-02-07 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-07 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-01-29 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.